Table 1 Baseline characteristics of patients implanted with the HeartMate II (HMII) and HeartWare (HVAD)
HMII (n = 105) | HVAD (n = 34) | p-value | |
|---|---|---|---|
Age | 56.5 + 13.9 | 57.2 + 14.6 | 0.82 |
Sex male, n (%) | 83 (79.1) | 27 (81.8) | 0.73 |
Body mass index | 29.2 + 6.8 | 29.5 + 6.2 | |
LVAD Indication, n (%) | 0.89 | ||
Bridge to transplantation | 28 (26.7) | 12 (35.3) | |
Destination therapy | 62 (59.1) | 18 (52.9) | |
Bridge to decision | 13 (12.4) | 1 (2.9) | |
Bridge to recovery | 2 (1.9) | 3 (8.8) | |
INTERMACS Classification | 0.19 | ||
1 | 12 (14.3) | 5 (14.7) | |
2 | 39 (37.1) | 14 (41.2) | |
3 | 36 (34.3) | 15 (44.1) | |
4 | 14 (13.3) | ||
5 | 1 (0.9) | ||
Heart failure duration, months | 2.2 + 1.1 | 2.3 + 0.8 | 0.59 |